r Despite their immense physiological and pathophysiological importance, we know very little about the biology of dense core vesicle (DCV) trafficking in the intact mammalian brain.
Introduction
Neuronal dense core vesicles (DCVs) represent a diverse group of large secretory granules containing an electron-dense core as defined by electron microscopy. DCV cargo molecules differ between neuronal subtypes and include a variety of signalling molecules like neuropeptides, neurotrophic factors (such as BDNF), guidance cues, extracellular proteases and others. These signalling molecules are important for a variety of functions including synaptic plasticity, neurotransmission, neuronal development and survival (Huang & Reichardt, 2001; Samson et al. 2006; Cohen & Greenberg, 2008; van den Pol, 2012) . Moreover, DCV cargos play important roles in several diseases such as social anxiety disorders (oxytocin and vasopressin) (Meyer-Lindenberg et al. 2011) ), stress disorders (NPY) (Reichmann & Holzer, 2015) and neurodegenerative diseases such as Alzheimer's disease (Reichmann & Holzer, 2015) . Despite their immense physiological and pathophysiological importance, we know very little about the biology of DCV trafficking in the intact mammalian brain.
DCVs are produced in the Golgi network (Kim et al. 2006 ) and transported via microtubule-dependent motor proteins (Zahn et al. 2004; Kwinter et al. 2009; Lo et al. 2011) towards their axonal or dendritic release sites. In contrast to synaptic vesicles, the content released by DCVs is not recycled locally, but degraded by membrane-or circulating metallo-endopeptidases (Rose et al. 2009 ). The highly dynamic transport of DCVs (Hartmann et al. 2001; de Wit et al. 2006; van de Bospoort et al. 2012; Wong et al. 2012; Farina et al. 2015; Gumy et al. 2017) ensures a reliable supply to often very distant locations in the axon and dendrites. Previous studies have shown an anterograde and retrograde cycling of DCVs through the axon with sporadic pauses in axonal en-passant boutons, also referred to as varicosities, which was concluded to represent an activity-dependent capture mechanism (Shakiryanova et al. 2006; Wong et al. 2012) . The function of this mechanism is probably to enhance availability of DCVs at synapses to facilitate regulated secretion. The fusion of DCVs with the plasma membrane mostly occurs at/near synapses and can be induced with electrical high-frequency stimulation in vitro (Hartmann et al. 2001; de Wit et al. 2009; van de Bospoort et al. 2012) . To date, it is not known if DCV transport in vivo is influenced by properties of the surrounding neuropil. Studies addressing DCV trafficking in the intact mammalian brain are lacking. The dense packaging of axonal and dendritic compartments within the neuropil could mechanically affect local trafficking conditions, in particular when considering that axons can have diameters of less than 100 nm (Berbel & Innocenti, 1988) , about the size of one DCV. Furthermore, neuro-glial interaction could affect DCV trafficking. In addition to these factors, different functional states of the brain such as sleep or wakefulness may have an impact on the properties of DCV trafficking and release. On a cellular level, different patterns of spontaneous and evoked activity in neurons in the intact brain, known to be more extensive than typically present in cultured neurons or acute brain slices, could significantly affect DCV transport properties. Until now, DCV transport was only studied in neuronal cell culture and model organisms like D. melanogaster (Wong et al. 2012) and C. elegans (Zahn et al. 2004) . Hence, to understand the contribution of aforementioned factors to DCV trafficking and to extrapolate published data obtained in reduced cell culture or brain slice preparations to living and behaving mammals, DCVs need to be imaged within the intact brain.
We established an in vivo DCV imaging approach using chronically implanted cranial windows and two-photon microscopy in anaesthetized and awake mice to describe the basic DCV transport characteristics in thalamocortical axons ramifying in the molecular layer of the primary motor cortex. We show that DCVs travel through thalamocortical axons in vivo with an average speed of 1 μm/s and maximal speeds of up to 5 μm/s with infrequent pauses. Furthermore, we show that DCVs preferentially slow down near presynaptic en-passant boutons. We propose this mechanism helps to promote synaptic localization and release of neuropeptides and neurotrophins.
Methods

Ethical approval
This study was carried out in accordance with the European Communities Council Directive (86/609/EEC) to minimize animal pain or discomfort. All experiments were conducted following the German animal welfare guidelines specified in the TierSchG. The local animal care and use committee (Regierungspräsidium Karlsruhe of the state Baden-Württemberg) gave approval for the study under the number G167/15. The authors declare that the reported experiments comply with The Journal of Physiology's ethical principles and its checklist on animal experimentation. Male C57Bl/6N mice were acquired from Charles River Laboratories (Sulzfeld, Germany) at an age of 8 weeks. The mice were kept at a 12-12 h dark-light cycle synchronized with the local day-night cycle. Water and food were available ad libitum, except for the imaging sessions. Mice were generally housed in ventilated racks with up to 3 animals per cage, but were separated after surgery to minimize the risk of injury. After completion of the experiments, mice were killed with an overdose of Narcoren (Merial GmbH, Hallbergmoos, Germany; 500 mg kg −1 bodyweight I.P.).
Immunohistochemistry
For immunohistochemistry, mice were deeply anaesthesised with Narcoren (500 mg kg −1 bodyweight I.P.) and transcardially perfused with 4% paraformaldehyde (PFA) in phosphate-buffered saline (PBS). The brains were post fixed overnight in 4% PFA and then sliced into 70 μm thick sections and stored in PBS. For increased permeabilization, the slices on which the chromogranin stains were performed on, were treated with 1% sodium dodecyl sulfate (SDS) in PBS for 5 min before the antibody stainings. For antibody staining the slices were incubated for 1 h in PBS containing 5% normal goat serum (NGS), 1% bovine serum albumin (BSA), 1% cold fish gelatin and 0.5% Triton X-100. Incubations with primary antibodies were done overnight at 4°C. The secondary antibodies were incubated for 1-2 h at room temperature. Primary antibodies were: Bassoon (Enzo Life Sciences, SAP7F407; 1:1000, RRID:AB 2313990), chromogranin A (Synaptic Systems, Göttingen, Germany, 259003; 1:500, RRID:AB 2619972), chromogranin B (Synaptic Systems, 259103, 1:500, RRID:AB 2619973), early endosomal antigene 1 (Eea1) (Abcam, Cambridge, UK; ab2900; 1:200, RRID:AB 2262056), Homer1 (Synaptic Systems, 160003; 1:200, RRID:AB 887730), Lamp-2 (Santa Cruz Biotechnology, Heidelberg, Germany, sc-18822; 1:200, RRID: AB 626858, kind gift from Ralph Nawrotzki), LC-3 (Medical & Biological Laboratories, Nagoya, Japan, M-152-3; 1:100; RRID:AB 1279144, kind gift from Ralph Nawrotzki), Piccolo (Synaptic Systems, 142104; 1:1000, RRID:AB 2619831), Rab5 (Abcam, ab18211; 1:200, RRID: AB 470264, kind gift from Ralph Nawrotzki). Alexa Fluor antibodies from Invitrogen were used as secondary antibodies in a dilution of 1:500. The slices were mounted in SlowFade Gold (Life Technologies) and imaged on a Leica SP8 inverted confocal microscope with a 63× oil immersion objective (NA = 1.4) and maximal resolution in x, y and z planes (0.08 μm × 0.08 μm × 0.3 μm).
Genetic labelling of DCVs and thalamo-cortical axons using viral gene transfer
DCVs were labelled in vivo in mice by viral expression of a fusion protein consisting of Neuropeptide Y (NPY) and the yellow fluorescent protein Venus (NPY-Venus) ( Fig. 1A and B) or the red fluorescent protein mCherry (van de Bospoort et al. 2012; Farina et al. 2015) , driven by the synapsin promoter. Axonal projections were labelled by expressing mCherry under the control of the CAG (chicken-beta-actin) promoter in thalamic projection neurons. Microtubule plus (+)-ends were marked by expression of green fluorescent protein (GFP) fused to the first 18 N-terminal amino acid residues of the microtubule +-end marking protein MACF43 fused to the two-stranded leucine zipper coiled-coil sequence corresponding to GCN4-p1 under control of the synapsin promoter as described elsewhere (Yau et al. 2016 ) (GFP-GCN4-MACF18). Recombinant adeno-associated virus (AAV) particles of the chimeric 1/2 serotype were produced with the plasmids described above (Schwenger & Kuner, 2010) .
Craniectomy, stereotaxic injection and chronic window implantation
For viral injection (Wimmer et al. 2004 ) and craniectomy (protocol adapted from Holtmaat et al. 2009 ), mice were anaesthetized with an intraperitoneal (I.P.) injection of a mixture of 0.48 μl fentanyl (1 mg/ml; Janssen), 1.91 μl midazolam (5 mg/ml; Hameln) and 0.74 μl medetomidin (1 mg/ml; Pfizer) per gram body weight each and placed in a stereotaxic head holder (Kopf). Depth of anaesthesia was monitored by checking for vibrissal movements, breathing frequency and pain reflexes. Before cutting of the skin, xylocaine solution (1%; Astra Zeneca) was injected subcutaneously. A small hole in the skull was made with a dental drill over the injection site. Then, 1 μl of a 1:1 mixture of the NPY-Venus and mCherry or a mixture of MACF-GFP and NPY-mCherry AAV particles was slowly injected into the right medio-dorsal thalamus (Coordinates from bregma: x = 1.13, y = -0.82, z = -3.28). Afterwards a circular craniectomy (approx. 6 mm, centre positioned 1 mm right of bregma) was drawn with a dental drill. The dura was carefully removed. A sterile round no. 0 coverslip with a diameter of 6 mm (cranial window) and a custom-made round plastic holder surrounding it for head fixation were cemented on the skull with dental acrylic (Hager & Werken) .
After surgery, mice received I.P. a mixture of 1.86 μl naloxon (0.4 mg/ml; Inresa), 0.31 μl flumazenil (0.1 mg/ml; Fresenius Kabi), 0.31 μl antipamezole (5 mg/ml; Pfizer) in 3.72 μl saline (0.9%; Braun) each per gram body weight to antagonize the anaesthesia. Mice were given carprofen (Rimadyl, 5 mg/kg; Pfizer) in saline before surgery and during the following days in intervals of 12 h for 3 days. Mice were single housed after surgery and typically imaged at least 21 days after J Physiol 596.16 the surgery. This waiting period is essential for the glial reaction below the window to subside (Holtmaat et al. 2009 ).
In vivo two-photon imaging
Two-photon imaging of small structures like DCVs provides a challenge that is illustrated in Fig. 1C and D. A DCV positioned anywhere within the focal volume will result in a similar signal. Single labelled DCVs compete with background autofluorescence signals (blue filled circles, Fig. 1C ). To be detectable, the fluorescence signal arising from the DCV will have to exceed the number of autofluorescence signals present in the background. DCVs located outside the focal volume will not be detected. Figure 1D illustrates the presence of two axons within . E, injection of AAVs encoding NPY-Venus and mCherry into the area of the right medio-dorsal thalamus (1). Position of objective for imaging (2). Note the orientation of superficial axons in parallel to the brain surface. F, chronic window implantation after stereotaxic delivery. G, setup for awake imaging. The mouse is fixed via the crown, but able to move on a freely rotatable disc. H, mosaic scan of thalamic injection site and axonal projection emanating from it (wide-field epifluorescence imaging of an 80 μm thick section; scale bar, 1 mm). Yellow rectangle depicts region of interest imaged in primary motor cortex, 30-80 μm below the pial surface. I, example image of a single frame used for in vivo two-photon time-lapse imaging 40 μm below the pial surface. mCherry-labelled axons (red) and NPY-Venus-labelled DCVs (green), DCVs in labelled axons appear yellow. Scale bar, 50 μm. J, magnified view of region marked in I. Scale bar, 10 μm.
a single focal volume, making it impossible to assign the total fluorescence recorded to the individual axons. Hence, imaging requires a low density of axons within the imaging volume. Multiple DCVs placed within the same axon and focal volume will be detected as a single, yet brighter, fluorescence spot. If these DCVs move together, it will be difficult to precisely identify the number of DCVs within that cluster. Two-photon imaging (Denk et al. 1994 ) was performed with a TriM Scope II microscope (LaVision BioTec GmbH) equipped with a pulsed Ti:Sapphire laser (Chameleon; Coherent). 960 nm was used for simultaneous excitation of both Venus and mCherry. For the experiments with MACF-GFP and NPY-mCherry, a wavelength of 995 nm was used. Imaging was performed with a 25× water immersion objective (Nikon MRD77225, NA = 1.1) and appropriate filter sets (Venus: 535/70 nm and mCherry: 650/100; Chroma). Fluorescence emission was detected with low-noise high-sensitivity photomultiplier tubes (PMTs, H7422-40-LV 5M; Hamamatsu). For the imaging sessions, anaesthesia was induced with 6% isoflurane (Baxter) in oxygen and maintained at 0.8-1%. Depth of anaesthesia was monitored by checking for vibrissal movements, breathing frequency and pain reflexes. The anaesthetized mouse was head fixed by clamping the plastic holder cemented to the skull. For awake imaging, the mouse was fixed over a rotatable disc treadmill ( Fig. 1G ) under isoflurane anaesthesia and the isoflurane was shut off after fixing. The awake imaging was started at least 5 min after the end of isoflurane anaesthesia. Frames were typically taken from an area of 196.6 × 196.6 μm at 1024 × 1024 pixel resolution with a frame rate of 1.06 Hz for 10 min per dataset using the galvanometric scanner of the TriM Scope II. Anaesthetized imaging sessions lasted no longer than 1 h and awake imaging sessions no longer than 20 min.
Processing and analysis of imaging data
The acquired movies were registered for image movement in the x-y plane with the Fiji (RRID:SCR 002285) Plugin 'Descriptor based series registration' (Preibisch et al. 2010) . Generally, during anaesthetized imaging sessions, resulting displacement in x-y was less than 10 μm. The resulting stacks were deconvolved using the Richardson-Lucy algorithm implemented in Matlab (RRID:SCR 001622) and a theoretical PSF, background subtracted and median-filtered. To only analyse moving particles, the average projection of the registered time lapse was subtracted from every image. For the semi-automated tracking of the DCV puncta the Fiji Plugin 'Trackmate' (Tinevez et al. 2016 ) was used. The automatically tracked parts were manually reviewed. The tracks were stopped when the puncta were not visible for more than two images. The resulting coordinates in x, y and t (time) were analysed with custom written Matlab scripts. Only tracks exceeding 10 consecutive images were analysed. The maximal speed per track was defined as highest mean of the speed out of 4 consecutive track points. The mean speed was averaged over all computed mean speeds of all tracks. The unidirectionality factor was defined as the fraction of the puncta moving in the direction of the main movement vector as defined by the first and last track point. To calculate this, each movement episode of all puncta present in the axon was classified to be forward or reverse with the unidirectionality factor defined as number of forward movements/number of reverse movements. Hence, an unidirectionality factor of 1 corresponds to a consistent movement of puncta in one direction while values below 1 indicate that some of the puncta also moved in the opposite direction. A value of 0.5 would indicate that the same number of puncta moved forward and reverse, suggesting no preferential movement direction.
The MACF18-GFP comets were analysed using kymographs. Lines fitted over tracks in the kymographs were analysed with an ImageJ macro written by Alessandro Moro which uses a kymograph plugin (Bioimaging and Optics Platform) (Seitz & Surrey, 2006) .
Statistics
All statistics were calculated using Prism (GraphPad, RRID:SCR 002798). Normality distribution of the data was tested using Kolmogorov-Smirnov, D'Agostino-Pearson and Shapiro-Wilk tests. Most analysed data did not show a gaussian distribution. Hence, distributions of the datasets were compared with non-parametric two-sided Mann-Whitney tests. A P value below 0.05 was considered statistically significant. Means reported in the text are given with the standard error of the mean (SEM) unless noted otherwise.
Results
To image DCVs in vivo, vesicles and axons were fluorescently labelled with NPY-Venus ( Fig. 1A-D ; see Methods for detailed discussion), a previously optimized DCV reporter (de Wit et al. 2009 ), and mCherry, using viral gene transfer into the right medio-dorsal thalamus (Fig. 1E) . Thalamo-cortical projection neurons were chosen as a model system, because their axons branch intracortically in the superficial layer 1 and run parallel to the surface of the brain, thereby providing ideal conditions for DCV imaging. Chronically implanted cranial windows (Fig. 1F ) permitted in vivo two photon microscopy in anaesthetized or awake mice (Fig. 1G) J Physiol 596.16 (Holtmaat et al. 2009 ). Three weeks after viral injection and chronic window insertion, imaging commenced using 960 nm excitation for simultaneous visualization of axons and labelled DCVs. The thalamic injection site and mCherry-labelled axonal projections reaching the surface of the brain are schematically indicated in Fig. 1H , with the yellow rectangle indicating an area situated 30-80 μm below the pial surface, from which time-lapse data were acquired. An example of an in vivo two-photon imaging experiment is shown in Fig. 1I , illustrating that labelling of thalamocortical axons with mCherry allowed detection of axons positioned within a single imaging frame, an important precondition to monitor moving DCVs (yellow dots in Fig. 1J , Supporting Movie S1). The signal of analysed vesicles shows a mean signal to noise ratio between 2:1 and 4:1 as measured by the mean fluorescence of the vesicle divided by the background, thus providing reliable imaging conditions.
The time-lapse movies regularly showed large static fluorescent clusters that did not overlap with the mCherry labelled axons. These might represent either cellular autofluorescent debris or released fluorescent cargo of the DCVs that has been taken up by cells, possibly astrocytes or microglia. Co-staining for an astrocytic marker and a marker of early endosomes demonstrated an overlap of a portion of this fluorescent cargo and astrocytic early endosomes (data not shown).
To control for the correct packaging of the DCV cargo reporter, NPY-Venus, into DCVs under in vivo conditions, we immunostained fixed brain slices with the endogenous DCV markers chromogranin A and B (Chr-A, Chr-B). NPY-Venus-labelled DCVs were detected in mCherry-labelled axons and overlapped with Chr-A and Chr-B stainings ( Fig. 2A and B) . We found no overlapping fluorescent signals of NPY-Venus puncta with other cellular structures such as endosomes, lysosomes, autophagosomes or presynaptic proteins ( Fig. 2C-H) . To exclude that expression of the DCV cargo reporter induced the formation of DCVs in cells that may not a priori produce DCVs, we labelled thalamic axons with mCherry and immunostained for Chr-A (data not shown). This experiment demonstrates the presence of DCVs in thalamocortical axons independent of the NPY-Venus expression. In summary, these results suggest that the DCV cargo reporter NPY-Venus correctly labelled DCVs in neurons that endogenously produce DCVs, consistent with previous observations made in cultured neurons (Taraska et al. 2003; Farina et al. 2015) .
Visualizing DCV movement in axonal projections in vivo
DCV trafficking in thalamocortical axons was monitored by time-lapse imaging of DCV reporter fluorescence and axonal fluorescence in single focal planes at 1 Hz. Individual DCV puncta can be assigned to the axons they are travelling in (Fig. 3A) and subsequently tracked (Fig. 3B) . Small fluctuations in the apparent size of the puncta along the trajectory may arise from axons not running perfectly in parallel to the imaging plane, so that different amounts of fluorescent proteins in the vesicles are excited (see Fig. 1C and D) . Alternatively, changes in the z focus position in response to slight movements of the tissue may account for fluctuations in apparent size of the puncta. The average length of axonal segments analysed was 30 ± 10 μm and time-lapse movies lasted for typically 10 min. At t = 2 s, the DCVs marked yellow and blue in Fig. 3B appear to travel within the same diffraction-limited focal volume. Such co-travelling events were encountered only rarely (on average less than once in each kymograph of 51 axon stretches analysed). During the time period from 2 s to 14 s, the puncta labelled green and orange travel with different speeds (1.6 μm/s; 0.6 μm/s) in the same direction. This is further illustrated in the kymograph (Fig. 3C) . Hence, tracing of labelled DCVs can be achieved with the approach introduced here, including quantitative analyses.
Quantification of DCV trafficking characteristics in vivo
Following the experimental scheme shown in Fig. 1 , a total of 279 vesicles in eight mice were tracked semi-automatically. The average speed of moving DCV puncta in vivo in anaesthetized mice was 1.03 ± 0.03 μm/s (Fig. 4A and J) . This is in agreement with previous observations in cultured mammalian neurons and with in vivo imaging performed in D. melanogaster, ranging from speeds of 0.75 μm/s to 1.25 μm/s for axonal DCV transport (see coloured points in Fig. 4A ) (de Wit et al. 2006; Kwinter et al. 2009; Bittins et al. 2010) .
The maximum speed per track was defined as the highest average speed within 4 consecutive track points of each track. The average maximum speed of the tracked vesicles was 2.06 ± 0.05 μm/s (Fig. 4B ), but we regularly observed speeds of up to 5 μm/s (in vitro data: 2.6 μm/s to 3.75 μm/s; de Wit et al. 2006; Bittins et al. 2010) .
DCV puncta often slowed down and stopped, but started moving again at a later time point (pausing). The pausing time was defined as the percentage of time that a punctum moved slower than 0.2 μm/s. This corresponds roughly to a displacement of one pixel per image. The overall pausing time of the tracked vesicles was 10.7 ± 0.7% (Fig. 4C) . This is lower than the 22% pausing fraction reported in cell culture (de Wit et al. 2006) .
It was not possible to determine whether DCV puncta moved in the anterograde or retrograde direction within the axon, because the position of the soma could not be determined in situ. To analyse if vesicles moved back and forth, or if they followed a preferred movement vector, the directionality factor for the overall movement of a vesicle was calculated. This 'unidirectionality factor' was defined as the fraction of time the vesicle moved along its overall directional vector defined by the first and last point of the track. The mean unidirectionality factor of all 279 analysed tracks is 0.86 ± 0.01 (Fig. 4D) . This corresponds to an overall consistent unidirectional movement of the puncta. The remaining 14% of movements were in the opposite direction to the main movement vector.
To compare the amount of bidirectional and unidirectional movement in individual axons, only axons with more than 5 tracked puncta were investigated to avoid a possible bias towards unidirectional movement. In total, 25 axons were analysed. The frequency distribution of the directionality in these axons shows that in approximately 40% of the axons DCVs move only in one direction (Fig. 4) . Bidirectional movement was observed in approximately 60% of the axons.
To test possible confounding effects on the trafficking characteristics due to different expression time and thus different amounts of DCV cargo reporter expressed, two mice were imaged twice, at 2-3 weeks and 8-9 weeks after viral injection (data not shown). No significant differences in the transport speeds and other trafficking characteristics of the NPY-Venus puncta were found between these time E-H, puncta tracked in awake mice (n = 46 puncta, 3 mice). No significant differences (Mann-Whitney test) were found for mean speed (P = 0.12), maximal speed (P = 0.28), and fraction paused (P = 0.22), while the directionality differed highly significantly (P = 0.0001). I, distribution of directionality of transport in axons with n > 4 tracked vesicles. J, frequency distributions of mean speeds in awake (black bars) and anaesthetized (grey bars) mice.
points, suggesting that the amount of reporter expressed did not affect the trafficking properties of DCVs. In summary, the basic DCV trafficking properties were similar in the anaesthetized intact brain in comparison to a large set of trafficking data previously described in neuronal cell cultures. However, in vivo, the peak speed was higher and the pausing time lower.
Comparison of DCV trafficking in anaesthetized and awake mice
To control for potential influence of anaesthesia, and thus brain activity levels in general, on DCV transport, three mice were imaged in the awake state. Minor axial movements exceeding 1-2 μm remove the axon stretch of interest from the imaging plane (see Fig. 1C and D) . Therefore, the base plate of the window was firmly fixed, both on the skull and in the holder, while placing the mouse on a rotatable disk (Fig. 1G) . The axial focal plane remained stable, except when the mice started to run. These episodes were excluded from further analysis. Forty-six tracks in awake and resting mice were analysed and trafficking characteristics from these tracks were compared to all tracks recorded from anaesthetized mice. The mean speed of DCV puncta was 1.17 ± 0.1 μm/s in the awake state and did not differ from the mean speed of 1.03 ± 0.03 μm/s in anaesthetized mice (Fig. 4E , Supporting Movie S2). This is further illustrated by the large overlap of the frequency histograms of both distributions (Fig. 4J) . The maximal speed and pausing time did not differ significantly between anaesthetized and awake mice (Fig. 4F and G) .
The only feature in DCV trafficking that was significantly different in the awake compared to anaesthetized mice was the lower directionality factor of 0.79 ± 0.03 in awake animals compared to 0.9 ± 0.01 (Mann-Whitney test, P = 0.0002) in anaesthetized animals (Fig. 4H ). This could potentially be explained by interfering movement of the animal that could not be corrected for during recordings. However, intrinsic differences caused by the activity state of the brain may also affect DCV movement directionality, leading to less straightforward tracks with more pausing and reversing of the movement direction.
Axonal microtubule dynamics in vivo
To differentiate between anterograde and retrograde DCV trafficking in vivo, we co-expressed NPY-mCherry and MACF18-GFP, a minimal fragment of the microtubule-actin cross-linking factor 2 that gets selectively incorporated at the microtubule +-end (Yau et al. 2016) . This allowed us not only to determine axonal orientation for trafficking analysis but also to characterize axonal microtubule growth dynamics. MACF18-GFP fluorescence accumulated at the growing microtubule plus ends are referred to as comets (Fig. 5, Supporting Movie S3). As overexpression of MT-plus end binding proteins can lead to the binding to all microtubules and not only the plus ends (Komarova et al. 2005) , we analysed these mice exclusively after 3-4 weeks of expression time, where punctate fluorescent and only faint cytoplasmic signals could be observed in axons. Analysis of the kymographs of MACF18-GFP comets allowed us to quantify movement speeds of axonal microtubules in vivo; 155 comets in 17 axons of four mice were analysed. We found a mean speed of axonal microtubule polymerization in vivo of 0.12 ± 0.01 μm/s (Fig. 5D ). This is in agreement with in vivo findings in spinal cord axons of 0.147 μm/s (Kleele et al. 2014) . The average run length of single comets was 10.02 ± 0.59 μm (Fig. 5E) . To compare the number of comets per axon stretch length and time to previously reported numbers, we calculated the number of comets per micrometer (μm) per minute (Fig. 5F ). With ß0.4 comets/min/20 μm (ß0.02 comets/min/μm) we observed fewer comets than the previously reported number of ß1.8 comets/min/20 μm (Yau et al. 2016) in dendrites. We found a density of 0.028 ± 0.0002 comets/μm which is in the range of the data reported by Kleele et al. (2014) in spinal cord axons (0.033 ± 0.002 comets/μm).
Anterograde versus retrograde DCV trafficking
Assessing the run direction of MACF18-GFP puncta allowed us to define the directionality of DCV movement within the same axon as anterograde or retrograde with respect to the soma. The unidirectional movement of multiple microtubule comets (green) within a single axon stretch define the orientation of this axon: anterograde corresponds to movement from left to right in the kymograph (Fig. 6A) . The movements of multiple DCVs in the same axonal stretch (red) reveal their dynamic bidirectional transport.
In the axons the mean speed of DCV transport in the anterograde direction was 2.14 ± 0.12 μm/s (n = 78) and in retrograde direction 1.4 ± 0.08 μm/s (n = 67; Fig. 6B ). This analysis showed a significant difference in transport speed (Mann-Whitney test, P < 0.0001). Additionally, we compared mean speeds of anterograde and retrograde transport within axons (with n > 2 vesicles in each direction). In almost all axons, the anterograde vesicles were faster than the retrograde vesicles (Fig. 6F) . The maximum speed, pausing time and unidirectionality factor showed significant differences in the antero-and retrograde trafficking directions (Fig. 6C-E) . Thus, in vivo imaging revealed a difference in anterograde and retrograde trafficking speed comparable to that previously published in cultured neurons (de Wit et al. 2006 ) and invertebrates (Zahn et al. 2004; Barkus et al. 2008) .
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DCV trafficking is different near axonal boutons in vivo
While analysing the tracking data, we noticed that some of the axons showed different trafficking features at sites that resembled en-passant boutons, visible as ellipsoid structures with a diameter of 2-4 μm (Fig. 7A,  red) . To confirm that these structures correspond to axonal boutons, we performed immunostainings for the pre-and postsynaptic markers synaptophysin and Homer1, respectively. NPY-Venus puncta overlapped with synaptophysin-positive puncta within ellipsoid structures of the axon (Fig. 7B ) and were associated with Homer1-positive puncta nearby (Fig. 7C) , indicating that the ellipsoid structures of typical size and shape represent presynaptic boutons.
Each of the boutons shown in Fig. 7A contains DCV puncta that turned out to be immobile or mobile (Fig. 7D , orange versus red circles). Upon passing the bouton, mobile puncta slow down near the boutons (red, see also trajectory in kymograph, Fig. 7E ). For the subsequent analysis, 57 tracks of axons with visible boutons from three mice were compared to tracks in axons lacking boutons. The average speed of DCV puncta was significantly lower in the axons containing boutons with a difference of 0.3 μm/s ( Fig. 7F ; bouton: 0.78 ± 0.11 μm/s; non-bouton: 1.10 ± 0.03 μm/s; MW: P < 0.0001). The maximal speed was significantly lower too, with a difference of 0.3 μm/s ( Fig. 7G ; bouton: 1.81 ± 0.16 μm/s; non-bouton: 2.16 ± 0.05 μm/s; MW: P < 0.0001). The pausing time of the vesicles was different, with a higher fraction of pausing vesicles in/around boutons ( Fig. 7H ; bouton: 20.43 ± 2.14%; non-bouton: 8.50 ± 0.61%; MW: P < 0.0001). Finally, changes in movement directionality were increased in axons containing boutons (Fig. 7I , 0.79 ± 0.02; non-bouton: 0.90 ± 0.01; MW: P < 0.0001).
To investigate further at which distance from the bouton center the reduction in speed occurred, all bouton centre points were marked manually. Mean speeds of tracks outside a certain distance from the centre were analysed covering a range of 1 to 10 μm (Fig. 7J) . A steady decrease in mean speed from ß 0.9 μm/s to ß 0.5 μm/s occurred within a distance of 10 μm towards the bouton centre. We conclude that a lower mean speed of vesicles within and near boutons leads to longer residence of trafficking DCVs in presynaptic boutons, facilitating the recruitment of DCVs for secretion in synaptic boutons.
Discussion
We characterized DCV trafficking dynamics in anaesthetized and awake mice in axons of thalamo-cortical projection neurons. Our experimental protocol allows imaging of fluorescently labelled neuronal DCVs through chronic cranial windows in mice, transferring basic cell biology from the culture dish to the more complex and realistic environment of higher order systems. While many axonal DCV trafficking properties previously described in vitro are similar to those revealed here in vivo, we found a higher peak transport speed, a lower fraction of pausing DCVs and a slow-down of DCV trafficking upon approach to axonal boutons. The latter is consistent with a preferential capture and release of DCVs at presynaptic sites in the anaesthetized and awake mouse brain.
NPY-Venus-labelled punctate structures showed the trafficking features of DCVs and were confirmed as such using staining for chromogranin A/B ( Fig. 2A  and B) . Furthermore, NPY-Venus signals did not overlap with other (mobile) organelles such as endosomes, lysosomes or autophagosomes, or presynaptic proteins ( Fig. 2C-H) . Together, these observations strongly indicate that NPY-Venus-labelled structures represent DCVs. The NPY-Venus puncta travelling through axons had different sizes and fluorescence intensities, suggesting that puncta may consist of either single or multiple DCVs ( Figs 1J, 3 and 7) , consistent with published in vitro data (van de Bospoort et al. 2012) . It has been argued that thalamocortical and pyramidal cortical neurons lack DCVs altogether (Torrealba & Carrasco, 2004) , although thalamic projection neurons have not been systematically investigated for DCVs. By selectively labelling thalamic projection neurons with mCherry and performing stainings of the endogenous DCV marker chromogranin A, we could demonstrate that DCVs naturally occur in these neurons. Hence, NPY-Venus expression did not artificially induce DCV biogenesis and, therefore, our study reports physiologically relevant processes. In addition to axonal fluorescent clusters, we also regularly found larger fluorescent clusters outside the axons. These clusters may reflect autofluorescent cellular debris near the pial surface, stable deposits of secreted DCV cargo or endocytosed fluorescent proteins within scavenger cells such as astrocytes or microglia, or in neurons. Such accumulations of DCV cargo after their release is a well-known phenomenon in coelomocytes of the nematode C. elegans (Zahn et al. 2004) . The DCV velocities and directionality of their transport determined here generally correspond well with previously reported data from in vitro experiments and studies in other model systems (Zahn et al. 2004; de Wit et al. 2006; Barkus et al. 2008; Kwinter et al. 2009; Bittins et al. 2010) . The higher peak speed and shorter pausing time observed in vivo might be due to different temperatures in cell culture experiments or the fact that axonal microtubule orientation is different in mammals and invertebrates (del Castillo et al. 2015) . Furthermore, neuronal activity patterns are probably different in vitro and in vivo and lead to a different amount of arrest, as DCV arrest is induced by activity (de Wit et al. 2006) . Finally, we observed a wide range of DCV trafficking patterns: Faster vesicles passing slower ones in the same direction, vesicles first travelling alone, then together to finally be separated again, vesicles passing each other in different directions, most vesicles slowing down mid-travel to pause for a short time and others travelling with a constant speed over the whole tracked distance. The frequent changes in movement speed and also directionality may be due to different motor proteins of the kinesin family bound to the same vesicle, possibly in combination with a dynein motor, thereby defining the speed of the vesicles as a product of the individual speeds of the motors involved (Gumy et al. 2017) . Another reason for the directionality changes might be switching between different motor proteins. These diverse in vivo trafficking patterns resemble patterns previously observed in vitro (de Wit et al. 2006 ). In conclusion, the general properties of DCV trafficking in the intact mouse brain are in agreement with previous findings in neuronal primary cell culture and invertebrates. This may be attributed to the high conservation of motor proteins that are responsible for DCV transport in all investigated model systems (Zahn et al. 2004; Barkus et al. 2008) .
Coexpression of the microtubule marker MACF18-GFP with the DCV marker NPY-mCherry allowed us to distinguish between anterogradely and retrogradely moving DCVs. The mean speed of all anterogradely travelling DCVs was 2.14 μm/s, approximately 50% faster than vesicles moving retrogradely, at 1.4 μm/s. This is in accordance with findings from cultured hippocampal neurons, but in opposition to findings at Drosophila neuromuscular junction, where DCVs move antero-and retrogradely at roughly the same speed (Shakiryanova et al. 2006; Barkus et al. 2008) . Our findings are consistent with speeds reported for motor proteins recruited for axonal anterograde and retrograde movement, with kinesins moving DCVs considerably faster than dynein (Maday et al. 2014) . The overall higher mean speed reported in Fig. 6 compared with that reported in Fig. 4 might be attributed to the fact that we only analysed axonal stretches containing multiple moving DCVs, potentially interfering with trafficking speed. Furthermore, overexpression of MACF18-GFP might enhance microtubule growth rate or stabilize microtubules. This could lead to elongation of microtubule tracks and thus less pausing and higher mean speeds. In conclusion, the anterograde trafficking speed of DCVs is approximately 50% faster than retrograde transport in vivo.
MACF18-GFP allowed us to monitor axonal microtubule dynamics in the cerebral cortex in vivo. We found a unidirectional polarity of axonal movement of microtubules in vivo with a comet run length of around 10 μm. In comparison to developing neurons, the number of moving comets/unit of axon length is relatively small (Conde & Cáceres, 2009 ). The mean speed of comet growth was 0.12 μm/s, in agreement with findings of other in vivo studies in spinal cord axons of 0.147 μm/s (Kleele et al. 2014) and 0.09 μm/s in dendrites of cortical neurons (Yau et al. 2016) .
The newly discovered reduction in transport speed and longer pausing times at axonal en-passant boutons may be a mechanism to increase the availability of DCVs at presynaptic sites (Wong et al. 2012) , consistent with the notion that these sites accumulate the protein complexes that drive exocytosis and are the main locations of DCV capture and release (Torrealba & Carrasco, 2004) . The mechanism that reduces DCV speed remains unclear. Several mutually non-exclusive possibilities are plausible.
(1) Axonal en-passant boutons are small compartments packed with proteins, mitochondria and synaptic vesicles. Molecular (or organelle-) crowding could contribute to slowing of DCV transport through these structures, as indicated by diffusion models in boutons (Wragg et al. 2015) . (2) DCVs are mainly transported via microtubule-mediated transport mechanisms (Barkus et al. 2008) . The slowing could be caused by shorter microtubule tracks in and around boutons, causing more frequent switches between tracks, in turn leading to an effective slowing and more frequent directional changes. (3) Microtubule-mediated transport is regulated through post-translational modifications of tubulins (Schlager et al. 2009 ), or motor proteins (Akhmanova & Hammer, 2010; Hirokawa et al. 2010) . Synapses may accumulate kinases and other modifying enzymes to specifically affect trafficking speed at synapses. (4) DCVs are not only transported via microtubule-dependent motors, but also via actin-dependent myosin motors (Bittins et al. 2010) . The presynaptic actin-myosin network may play a role in tethering DCVs to the membrane and in DCV release (Papadopulos et al. 2015) . The highly local actin-myosin motors may also contribute to the slowing of DCV transport at presynaptic boutons. (5) Finally, fast axonal transport of DCVs is known to be inhibited by activity in a Ca 2+ -dependent manner (de Wit et al. 2006) . Because Ca 2+ -channels are known to accumulate in presynaptic specializations, endogenous activity in the axons will preferentially increase intracellular free Ca 2+ in boutons and slow down DCV trafficking in this area. However, J Physiol 596.16 the slowing effect was also observed in anaesthetized mice, presumed to have a lower neuronal activity. Taken together, a number of possible mechanisms may explain the slowing of DCVs in axonal boutons to increase their availability at presynaptic sites.
